Patrick Vanderheyden

3.8k total citations
111 papers, 3.2k citations indexed

About

Patrick Vanderheyden is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Patrick Vanderheyden has authored 111 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 58 papers in Cellular and Molecular Neuroscience and 38 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Patrick Vanderheyden's work include Receptor Mechanisms and Signaling (84 papers), Neuropeptides and Animal Physiology (40 papers) and Renin-Angiotensin System Studies (38 papers). Patrick Vanderheyden is often cited by papers focused on Receptor Mechanisms and Signaling (84 papers), Neuropeptides and Animal Physiology (40 papers) and Renin-Angiotensin System Studies (38 papers). Patrick Vanderheyden collaborates with scholars based in Belgium, Hungary and United States. Patrick Vanderheyden's co-authors include Georges Vauquelin, Frederik Fierens, Yvette Michotte, Jean‐Paul De Backer, Guy Ebinger, Sophie Sarre, J.-P. De Backer, Ilse Smolders, Heidi Demaegdt and László Hunyady and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Circulation Research.

In The Last Decade

Patrick Vanderheyden

109 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Vanderheyden Belgium	35	2.0k	1.2k	1.2k	567	271	111	3.2k
A. De Léan Canada	31	3.2k 1.6×	2.0k 1.6×	835 0.7×	711 1.3×	279 1.0×	69	4.7k
Michael Entzeroth Germany	29	1.5k 0.8×	1.3k 1.0×	433 0.4×	276 0.5×	171 0.6×	52	3.0k
Grant A. McPherson Australia	22	2.0k 1.0×	1.5k 1.2×	817 0.7×	289 0.5×	114 0.4×	64	3.7k
André De Léan Canada	27	1.5k 0.8×	736 0.6×	741 0.6×	359 0.6×	128 0.5×	64	2.5k
Canan G. Nebigil France	31	1.7k 0.9×	623 0.5×	743 0.6×	180 0.3×	263 1.0×	67	3.2k
L E Limbird United States	36	3.0k 1.5×	1.8k 1.5×	454 0.4×	275 0.5×	142 0.5×	60	4.4k
Joachim Neumann Germany	42	3.6k 1.8×	856 0.7×	2.9k 2.5×	182 0.3×	109 0.4×	248	5.4k
Sergio Bova Italy	25	1.8k 0.9×	798 0.7×	711 0.6×	325 0.6×	104 0.4×	98	3.1k
Pierre Falardeau Canada	31	1.7k 0.9×	1.8k 1.5×	249 0.2×	280 0.5×	148 0.5×	95	4.0k
Nicole Defer France	30	2.2k 1.1×	710 0.6×	337 0.3×	207 0.4×	222 0.8×	81	3.1k

Countries citing papers authored by Patrick Vanderheyden

Since Specialization

Citations

This map shows the geographic impact of Patrick Vanderheyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Vanderheyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Vanderheyden more than expected).

Fields of papers citing papers by Patrick Vanderheyden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Vanderheyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Vanderheyden. The network helps show where Patrick Vanderheyden may publish in the future.

Co-authorship network of co-authors of Patrick Vanderheyden

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Vanderheyden. A scholar is included among the top collaborators of Patrick Vanderheyden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Vanderheyden. Patrick Vanderheyden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alexander, Wayne, Kenneth E. Bernstein, Kevin Catt, et al.. (2023). Angiotensin receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023(1). 2 indexed citations

Alexander, Wayne, Kenneth E. Bernstein, Kevin Catt, et al.. (2019). Angiotensin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019(4). 2 indexed citations

León, Luis F. De, José Dárias, Huzefa A. Raja, et al.. (2015). Phylogenetic Diversity of Sponge-Associated Fungi from the Caribbean and the Pacific of Panama and Their In Vitro Effect on Angiotensin and Endothelin Receptors. Marine Biotechnology. 17(5). 533–564. 23 indexed citations

Catalano, Alessia, Alessia Carocci, Antonia Di Mola, et al.. (2011). 1‐Pentanoyl‐N‐{[2'‐(1H‐tetrazol‐5‐yl)biphenyl‐4‐yl]methyl}‐pyrrolidine‐2‐carboxamide: Investigation of Structural Variations. Archiv der Pharmazie. 344(9). 617–626. 5 indexed citations

Bundel, Dimitri De, Heidi Demaegdt, Tony Lahoutte, et al.. (2009). Involvement of the AT₁receptor subtype in the effects of angiotensin IV and LVV‐haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory. Journal of Neurochemistry. 112(5). 1223–1234. 20 indexed citations

Demaegdt, Heidi, Minh Tâm Lê, Matthias Bauwens, et al.. (2008). Translocation of the insulin‐regulated aminopeptidase to the cell surface: detection by radioligand binding. British Journal of Pharmacology. 154(4). 872–881. 13 indexed citations

Demaegdt, Heidi, Jean‐Paul De Backer, Hilde Laeremans, et al.. (2006). Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme. European Journal of Pharmacology. 546(1-3). 19–27. 29 indexed citations

Sarre, Sophie, Patrick Vanderheyden, Georges Vauquelin, et al.. (2004). Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.. VUBIR (Vrije Universiteit Brussel).

Peeters, B.W.M.M., J.A.D.M. Tonnaer, C.L.E. Broekkamp, et al.. (2004). Short ReviewGlucocorticoid Receptor Antagonists: New Tools to Investigate Disorders Characterized by Cortisol Hypersecretion. Stress. 7(4). 233–241. 37 indexed citations

10.

Lê, Minh Tâm, et al.. (2003). Molecular characterization of the high‐affinity [³H]neuropeptide Y‐binding component from the venom of Conus anemone. Fundamental and Clinical Pharmacology. 17(4). 457–462. 2 indexed citations

11.

Vauquelin, Georges, Isabelle Van Liefde, & Patrick Vanderheyden. (2002). Models and methods for studying insurmountable antagonism. Trends in Pharmacological Sciences. 23(11). 514–518. 53 indexed citations

12.

Vanderheyden, Patrick, et al.. (2002). The In Vitro Binding Properties of Non-Peptide AT1 Receptor Antagonists. Journal of clinical and basic cardiology. 5(1). 75–82. 2 indexed citations

13.

Lê, Minh Tâm, Patrick Vanderheyden, Geert Baggerman, Jozef Vanden Broeck, & Georges Vauquelin. (2002). Formation of angiotensin-(1–7) from angiotensin II by the venom of Conus geographus. Regulatory Peptides. 105(2). 101–108. 1 indexed citations

14.

Caballero‐George, Catherina, Patrick Vanderheyden, Tess De Bruyne, et al.. (2002). In VitroInhibition of [³ H]-Angiotensin II Binding on the Human AT₁Receptor by Proanthocyanidins fromGuazuma ulmifoliaBark. Planta Medica. 68(12). 1066–1071. 32 indexed citations

15.

Vanderheyden, Patrick, et al.. (2001). Tight binding of the angiotensin AT1 receptor antagonist [3H]candesartan is independent of receptor internalization11Abbreviations: candesartan, 2-ethoxy-1-[(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-1H-benzimidazoline-7-carboxylic acid; CHO-K1, Chinese hamster Ovary cells; CHO-hAT1 cells, CHO-K1 cells expressing human AT1 receptors; CHO-rAT1A-WT, CHO-K1 cells expressing wild type rat AT1A receptors; CHO-TL314-rAT1A, CHO-K1 cells expressing rat AT1A receptors with a truncated cytoplasmic tail at Leucine 314; HEPES, N-[2-hydroxyethyl]piperazine-N′-[ethanesulfonic acid]; IP, inositol mono-, bis- and trisphosphates.. Biochemical Pharmacology. 61(10). 1227–1235. 20 indexed citations

16.

Vanderheyden, Patrick, et al.. (2000). Inhibition of Angiotensin II-Induced Inositol Phosphate Production by Triacid Nonpeptide Antagonists in CHO Cells Expressing Human AT1 Receptors. Pharmaceutical Research. 17(12). 1482–1488. 5 indexed citations

17.

Fierens, Frederik, et al.. (1999). Binding of the antagonist []candesartan to angiotensin II AT1 receptor-tranfected Chinese hamster ovary cells. European Journal of Pharmacology. 367(2-3). 413–422. 82 indexed citations

18.

Fierens, Frederik, Patrick Vanderheyden, Jean‐Paul De Backer, & Georges Vauquelin. (1999). Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding. European Journal of Pharmacology. 372(2). 199–206. 81 indexed citations

19.

Vanderheyden, Patrick, Isabelle Van Liefde, J.-P. De Backer, & Georges Vauquelin. (1998). [³H]-BIBP3226 and [³H]-NPY Binding to Intact SK-N-MC Cells and CHO Cells Expressing the Human Y₁Receptor. Journal of Receptors and Signal Transduction. 18(4-6). 363–385. 10 indexed citations

20.

Keyser, Jacques De, Guy Ebinger, Jean‐Paul De Backer, et al.. (1988). Subtypes of adrenergic and dopaminergic receptors in bovine cerebral blood vessels. Neuroscience Letters. 85(2). 272–276. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact